MYCOBACTERIUM ABSCESSUS INFECTION
Clinical trials for MYCOBACTERIUM ABSCESSUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new MYCOBACTERIUM ABSCESSUS INFECTION trials appear
Sign up with your email to follow new studies for MYCOBACTERIUM ABSCESSUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental virus therapy targets Drug-Resistant lung infection
Disease control ENROLLING_BY_INVITATIONThis study tests a new treatment for a hard-to-treat lung infection caused by Mycobacterium abscessus. The therapy uses a specially chosen virus (bacteriophage) alongside standard antibiotics to try to reduce the amount of bacteria in the lungs. Only one person will take part, an…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE1 • Sponsor: Vancouver Coastal Health • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New hope against drug-resistant lung bug: contezolid shows early promise
Disease control ENROLLING_BY_INVITATIONThis study tests a new antibiotic called contezolid in 24 adults with a stubborn lung infection caused by Mycobacterium abscessus. Participants take the drug alone for 14 days, and researchers measure how much the bacteria level drops in their sputum compared to a standard antibi…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE2 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC